SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.
about
Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experienceDefective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer.Development of a syngeneic mouse model of epithelial ovarian cancer.Oncogenic stress sensed by the immune system: role of natural killer cell receptorsPotent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapySimultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice.Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients.Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancerHuman CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigensHuman prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer.Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.The structure and function of endophilin proteins.Unmasking the immune recognition of prostate cancer with CTLA4 blockade.Endophilin B2 facilitates endosome maturation in response to growth factor stimulation, autophagy induction, and influenza A virus infection.Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.Role of OGR1 in myeloid-derived cells in prostate cancer.Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ.CTLA-4 blockade synergizes with cryoablation to mediate tumor rejectionIntratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity.
P2860
Q26995499-DD05AB06-7FA3-4609-A6FD-59508B3CF09AQ33622444-45BF1AAE-3976-41F2-995E-299DE404A3F2Q34228613-55D47BBF-4A44-42B6-A46D-123432AEE9BFQ34282708-21BEEFD6-96AD-4491-BF36-5B72C9BE6DD0Q34473267-CC53FEC2-C907-4052-84D7-CA17A3F45A3DQ35920288-0AEDF36F-4379-4875-9791-B5FDC925136EQ35924987-9B756CAC-3D47-47C0-8E32-65FDD8EEB791Q36016696-BE36B929-84A2-4378-80AF-792500EDA4F2Q36021163-FAA43631-BC0B-4779-B954-06A920B25BE7Q36252546-6AF0432A-A2E6-4ED9-A768-7F6B6641C10AQ36303665-7C441970-F5A1-4E66-B6AA-620CACCE4E30Q37149887-4C19A603-67CF-4FBF-B291-3D3E8F5D10EEQ37435472-61192993-9F58-4514-A35C-BD24EAA207F7Q37685855-9A704C8B-7A3A-479C-98FA-0CB83C98BD24Q37756926-EE872481-0019-43EF-9A6B-90588A8B7858Q37823861-F9EE2E42-A65B-4A0E-AFDD-686AA3F01A6FQ37989393-5A704053-5809-4052-8465-FAB4D60C534FQ38705560-DE535FE7-51AC-44E2-945E-094B9E204C44Q39143599-54B109AB-EED2-4F7A-9F66-279AD6B27D23Q39230162-0900BE5E-C29A-40A1-A712-2C2CB385E435Q41012572-D64324CF-916D-48FB-92FD-79C28CACB3F1Q42214233-413DEB7F-75E7-4EE7-9226-FB4DBF72F75BQ54734909-43422461-C746-40B3-8D4D-6952979BFFFF
P2860
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
SPAS-1 (stimulator of prostati ...... identified by CTLA-4 blockade.
@ast
SPAS-1 (stimulator of prostati ...... identified by CTLA-4 blockade.
@en
type
label
SPAS-1 (stimulator of prostati ...... identified by CTLA-4 blockade.
@ast
SPAS-1 (stimulator of prostati ...... identified by CTLA-4 blockade.
@en
prefLabel
SPAS-1 (stimulator of prostati ...... identified by CTLA-4 blockade.
@ast
SPAS-1 (stimulator of prostati ...... identified by CTLA-4 blockade.
@en
P2093
P2860
P356
P1476
SPAS-1 (stimulator of prostati ...... identified by CTLA-4 blockade.
@en
P2093
Lawrence Fong
Marcella Fassò
Nilabh Shastri
Norman M Greenberg
Rebecca Waitz
P2860
P304
P356
10.1073/PNAS.0712269105
P407
P577
2008-02-26T00:00:00Z